Genetic determination of the prognosis in survivors of acute coronary syndromes. Study design and rationale for a multicenter study

Cor et Vasa

Volumn 49, Issue 4, 2007, Pages 134-137

  Pitha, Jan ^a   Hubáček, Jaroslav A ^a   Poledne, Rudolf ^a   Staněk, Vladimír ^a   Aschermann, Michael ^b   Gebauerová, Marie ^a   Hájek, Petr ^c   Niederle, Petr ^d   Pěnička, Martin ^e   Veselka, Josef ^c  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d NA HOMOLCE HOSPITAL   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acute coronary syndrome; Genetic polymorphism; Population based study

Indexed keywords

CONNEXIN 37; LYMPHOTOXIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROMELYSIN;

ACUTE CORONARY SYNDROME; ADULT; ALLELE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY CARE UNIT; CZECH REPUBLIC; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; REVIEW; SURVIVAL RATE;

EID: 34247626839     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2007.051     Document Type: Review

References (21)

1. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 2002;252:247-54.
2. Marienberg ME, Risch N, Bergman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. New Engl J Med 1994; 330:1041-6.
3. Morange PE, Henry M, Frere C, Juhan-Vague I; HIFMECH study group. Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infarction. Blood 2002;99:1878-9.
4. Liu PY, Li YH, Chan SH, et al. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. Am J Cardiol 2006;98:1012-7.
5. Mangino M, Braund P, Singh R, et al. LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians. Atherosclerosis 2006 [Epub ahead of print].
6. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 2005;294: 1526-33.
7. Shiffman D, Rowland CM, Louie JZ, et al. Gene variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction. Arterioscler Thromb Vasc Biol 2006;26:1613-8
8. Winkelmann BR, Marz W, Boehm BO, et al. Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogen 2001;2:S1-S73.
9. Clarke R, Xu P, Bennett D, et al. International Study of Infarct Survival (ISIS) Collaborators Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet 2006;2:e107.
10. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. New Engl J Med 2002;347:1916-23.
11. Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32:650-4.
12. Hubáček JA, Poledne R. Apolipoprotein E and its role in lipid metabolism, cardiovascular disease and Alzheimer disease. Prakt Lék 1998;78:162-5.
13. Widimsky P, Budesinsky T, Vorac D, et al. 'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicenter trial-PRAGUE-2. Eur Heart J 2003; 24:94-104.
14. Stanek V, Gebauerová M, Horák J, et al. Change in the fate of middle-aged men with acute myocardial infarction. Cor Vasa 2004;46:319-25.
15. Day N, Humphries SE. Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem 1994;222:389-95.
16. Hubáček JA. PCR - polyrmerase chain reaction. Principles and applications in research and medical practice. Čas Lék čes 1996;135:611-3.
17. Wong CW, Christen T, Roth I, et al. Connexin 37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006;12:950-4.
18. Wong CW, Christen T, Pfenniger A, James RW, Kwak BR. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis 2006;[Epub ahead of print].
19. Mizuno H, Sato H, Sakata Y, et al. Osaka Acute Coronary Insufficiency Study (OACIS) Group. Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction. Atherosclerosis 2006;185:400-5.
20. Liu PY, Li YH, Chan SH, et al. Genotype-phenotype association of matrix metallo-proteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. Am J Cardiol 2006;98:1012-7.
21. Ding J, Nicklas BJ, Fallin MD, et al. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke. Am Heart J 2006;152:1109-15.